Literature DB >> 3476305

Effect of enoxacin on colonic microflora of healthy volunteers.

C Edlund, A Lidbeck, L Kager, C E Nord.   

Abstract

Ten healthy volunteers received 400 mg enoxacin orally twice daily for seven days. Fecal specimens were collected at 0, 2, 4, 7, 9, 11, 16 and 21 days to study the effect of enoxacin on the normal colonic microflora. On the seventh day the fecal mean concentration of enoxacin was 348 mg/kg feces. Whereas enterobacteria were strongly suppressed during the administration of enoxacin, the gram-positive and anaerobic microflora was not significantly altered. Two weeks after enoxacin was discontinued, the colonic microflora had returned to normal.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3476305     DOI: 10.1007/BF02017617

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  8 in total

1.  In-vitro activity of enoxacin, ofloxacin, norfloxacin and nalidixic acid.

Authors:  A Bauernfeind; U Ullmann
Journal:  J Antimicrob Chemother       Date:  1984-09       Impact factor: 5.790

Review 2.  Impact of antimicrobial agents on the gastrointestinal microflora and the risk of infections.

Authors:  C E Nord; L Kager; A Heimdahl
Journal:  Am J Med       Date:  1984-05-15       Impact factor: 4.965

3.  The clinical pharmacokinetics and tolerance of enoxacin in healthy volunteers.

Authors:  R Wolf; R Eberl; A Dunky; N Mertz; T Chang; J R Goulet; J Latts
Journal:  J Antimicrob Chemother       Date:  1984-09       Impact factor: 5.790

4.  Colonization resistance of the digestive tract: clinical consequences and implications.

Authors:  D van der Waaij
Journal:  J Antimicrob Chemother       Date:  1982-10       Impact factor: 5.790

5.  Serum and sputum concentrations of enoxacin after single oral dosing in a clinical and bacteriological study.

Authors:  B I Davies; F P Maesen; J P Teengs
Journal:  J Antimicrob Chemother       Date:  1984-09       Impact factor: 5.790

6.  Effect of phenoxymethylpenicillin and clindamycin on the oral, throat and faecal microflora of man.

Authors:  A Heimdahl; C E Nord
Journal:  Scand J Infect Dis       Date:  1979

7.  In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim.

Authors:  N X Chin; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

8.  The activity of enoxacin against clinical bacterial isolates in comparison with that of five other agents, and factors affecting that activity.

Authors:  D S Reeves; M J Bywater; H A Holt
Journal:  J Antimicrob Chemother       Date:  1984-09       Impact factor: 5.790

  8 in total
  7 in total

Review 1.  Effect of quinolones on the human intestinal microflora.

Authors:  C E Nord
Journal:  Drugs       Date:  1995       Impact factor: 9.546

Review 2.  Enoxacin: a reappraisal of its clinical efficacy in the treatment of genitourinary tract infections.

Authors:  S S Patel; C M Spencer
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

Review 3.  Effect of quinolones on intestinal ecology.

Authors:  C Edlund; C E Nord
Journal:  Drugs       Date:  1999       Impact factor: 9.546

Review 4.  Impact of the fluoroquinolones on gastrointestinal flora.

Authors:  V Korten; B E Murray
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 5.  A review on the impact of 4-quinolones on the normal oropharyngeal and intestinal human microflora.

Authors:  C Edlund; C E Nord
Journal:  Infection       Date:  1988       Impact factor: 3.553

Review 6.  Quinolones and the gastrointestinal tract.

Authors:  B E Murray
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

Review 7.  Clinical overview of enoxacin.

Authors:  S H Zinner
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.